The NASDAQ Stock You Need To Be Watching!

While recession and inflation concern plague Wall Street, savvy investors look for opportunity. Unsubscribe A Message from Finimize The e-commerce opportunity is hard to dismiss and this quietly trading company is raking in multi-millions…. As a multifaceted brand owner, one emerging company has established brands in the health, wellness, pet, beauty, and other growing markets. Quietly trading on the NASDAQ, it may be just a matter of time before Wall Street uncovers the company. Last year they executed a successful business model to acquire leading, profitable, data-rich brands. Revenue, gross profit margin, and adjusted EBITDA have increased YOY as a result. This company trading for just a few dollars is now well positioned through many acquisitions. With a strong cash flow, and a CEO who has previously helped another company reach $17B in revenues, there could be substantial growth ahead. Second-quarter financial results will be released later this month and may be just the catalyst needed to generate a big breakout! Learn how there could be astronomical growth ahead for the company which expects a massive $100 million in revenues this year!

This message is a paid advertisement sent on behalf of Finimize, a third-party advertiser of MarketBeat. Why did I receive this email?     This message is a paid advertisement for Upexi (NASDAQ: UPXI) from Interactive Offers and Finimize. American Consumer News, LLC dba MarketBeat receives a fixed fee for each subscriber that clicks on a link in this email, totaling up to $6,000. Other than the compensation received for this advertisement sent to subscribers, MarketBeat and its principals are not affiliated with either Interactive Offers or Finimize. MarketBeat and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither MarketBeat nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from MarketBeat to buy or sell any security. MarketBeat has not evaluated the accuracy of any claims made in this advertisement. MarketBeat recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding Upexi (NASDAQ: UPXI) on Finimize' website for additional information about the relationship between Finimize and Upexi (NASDAQ: UPXI).     If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com or leave us a voicemail at (844) 978-6257.   If you would no longer like to receive promotional emails from MarketBeat advertisers, you can unsubscribe or manage your mailing preferences here.   © 2006-2023 American Consumer News, LLC dba MarketBeat. 326 E 8th St #105, Sioux Falls, SD 57103. United States.   Today's Bonus Content: BREAKING: Tiny biotech successfully treats blindness